Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationNote: All Grants Are U.S. Funded Through 2018
DIPG Registry - $219,000
$219,000.00 USD
January 2012
Establishment of an International DIPG Registry
Texas Children's Cancer Center - $100,000
$100,000.00 USD
November 2011
Eliminating Therapy-Resistant Diffuse Intrinsic Pontine Gliomas with Oncolytic Picorna Virus SVV-001
Duke University - $82,049
$82,049.00 USD
November 2011
Preclinical Evaluation of Systemic and Direct Delivery of a PDGFR-Alpha Antibody
Doernbecher Children's Hospital - $100,000
$100,000.00 USD
November 2011
Rapid Preclinical Development of a Targeted Therapy Combination for DIPG.
Sydney Children's Hospital - $100,000 USD / $100,420 AUD (Approx)
$100,000.00 USD
August 2011
Robotic screening for novel therapies for diffuse pontine gliomas
St. Jude's Children's Research Hospital - $35,000
$35,000.00 USD
September 2010
PI3K signaling effectors in DIPG
Cincinnati Children's Hospital - $35,000
$35,000.00 USD
September 2010
Establishment of a pre-clinical model for pediatric glioblastoma
Cincinnati Children's Hospital - $75,000
$75,000.00 USD
March 2010
Telomerase: A Therapeutic Target in Pediatric Brain Tumors
Weill Cornell Medical College - $91,740
$91,740.00 USD
March 2010
Phase I Study of tumor-targeting Convection-Enhanced Delivery (CED) of radio immunotherapy for Diffuse Pontine Glioma in Children.
St. Jude's Children's Research Hospital - $10,000
$10,000.00 USD
July 2009
Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.
Cincinnati Children's Hospital - $50,000
$50,000.00 USD
July 2009
National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
St. Jude's Children's Research Hospital - $50,000
$50,000.00 USD
July 2009
Phase I Study of the combination of Vandetanib and Dasatinib administered during and after radiation therapy in the children with newly diagnosed DIPG.
Cincinnati Children's Hospital - $50,000
$50,000.00 USD
September 2008
Study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
St. Jude's Children's Research Hospital - $25,000
$25,000.00 USD
September 2008
Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.